High-Dose Influenza Vaccine to Reduce Hospitalizations

Jacobo Pardo-Seco

Genetics, Vaccines, and Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain

Carmen Rodríguez-Tenreiro-Sánchez

Genetics, Vaccines, and Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain

Iago Giné-Vázquez

Genetics, Vaccines, and Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain

Narmeen Mallah

Genetics, Vaccines, and Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain

Susana Mirás-Carballal

Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Santiago de Compostela, Spain

Marta Piñeiro-Sotelo

Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Santiago de Compostela, Spain

Martín Cribeiro-González

Dirección Xeral de Recursos Económicos, SERGAS, Xunta de Galicia, Santiago de Compostela, Spain

Mónica Conde-Pájaro

Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Santiago de Compostela, Spain

Juan-Manuel González-Pérez

Subdirección de Sistemas y Tecnologías de la Información, Consellería de Sanidade, Xunta de Galicia, Santiago de Compostela, Spain

Irene Rivero-Calle

Genetics, Vaccines, and Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain

Xabier Bello

Genetics, Vaccines, and Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain

Josefina Lorena Razzini

Genetics, Vaccines, and Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain

Ana Dacosta-Urbieta

Genetics, Vaccines, and Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain

Antonio Salas

Genetics, Vaccines, and Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain

Rebecca C. Harris

Sanofi, Singapore

Matthew M. Loiacono

Sanofi, Morristown, NJ

Robertus van Aalst

Joan Manel Farré

Sanofi Vaccines, Barcelona

Marine Dufournet

Sanofi, Lyon, France

Niklas Dyrby Johansen

Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Copenhagen

Daniel Modin

Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Copenhagen

Tor Biering-Sørensen

Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Copenhagen

Carmen Durán-Parrondo

Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Santiago de Compostela, Spain

Federico Martinón-Torres

Genetics, Vaccines, and Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain